<ѻýҕl>Melanoma Patient on Immunotherapy Develops Severe Dermatitisѻýҕl> Clinicians faced with presumed dermatologic AEs urged to consider all differentials Jan 10, 2022
<ѻýҕl>Long-Term Data Reinforce Standard of Care in Unresectable Melanomaѻýҕl> Landmark trial shows median OS of 72.1 months with nivolumab-ipilimumab Dec 01, 2021
<ѻýҕl>Case: VEGFR Inhibition in Merkel Cell Carcinoma Patientѻýҕl> Disease stabilized after post-chemotherapy progression of the aggressive neuroendocrine cancer Oct 11, 2021
<ѻýҕl>FDA Issues Orders Clarifying Rules for Marketing Sunscreensѻýҕl> But more studies on sunscreen chemicals are still needed, advocacy group says Sep 24, 2021
<ѻýҕl>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻýҕl> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻýҕl>Adjuvant Pembrolizumab Boosts Recurrence-Free Survival in High-Risk Melanomaѻýҕl> Also, fewer cases of distant recurrences in KEYNOTE-716 trial Sep 19, 2021
<ѻýҕl>What's Causing Cancer Patient's Joint Pain While on Checkpoint Inhibitor?ѻýҕl> Here is how clinicians diagnosed this rare inflammatory side effect Aug 30, 2021
<ѻýҕl>COVID Surges Emerge; FDA Warns About Chantix; Lions, Tigers, Bears Get Vaxxedѻýҕl> A daily roundup of news on COVID-19 and the rest of medicine Jul 06, 2021
<ѻýҕl>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survivalѻýҕl> News, features, and commentary about cancer-related issues Jun 16, 2021
<ѻýҕl>Adjuvant Anti-PD-1 Misses on OS in High-Risk Melanomaѻýҕl> But pembrolizumab topped active controls for relapse-free survival Jun 07, 2021
<ѻýҕl>Lymph Node Findings on PET: Cancer or COVID Vaccine?ѻýҕl> Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<ѻýҕl>Bad Day Sunshine: Benzene Found in Many Sun Care Productsѻýҕl> Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
<ѻýҕl>Novel Immunotherapy Boosts Melanoma Outcomesѻýҕl> Adding LAG-3 checkpoint inhibitor to nivolumab extended PFS in patients with advanced disease May 19, 2021
<ѻýҕl>Doubling Down on Immunotherapy in Advanced Melanomaѻýҕl> Checkpoint inhibitor combo active after upfront anti-PD-1/L1 therapy May 09, 2021
<ѻýҕl>Op-Ed: Dermatology Needs Lower Costs and Better Careѻýҕl> A proposal for value-based care Apr 21, 2021
<ѻýҕl>Nivolumab Alone Prevails in Resected Melanomaѻýҕl> Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
<ѻýҕl>A Win for Adjuvant Immunotherapy in Esophageal Cancerѻýҕl> And other highlights from the Society of Surgical Oncology's virtual 2021 meeting Mar 31, 2021
<ѻýҕl>Want Data on Recently Approved Actinic Keratosis Drug? Here You Goѻýҕl> Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<ѻýҕl>First Immunotherapy Approved for Basal Cell Carcinomaѻýҕl> Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
<ѻýҕl>IL-8 Antibody Active in Tumors After PD-1/L1 Blockadeѻýҕl> Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo Nov 13, 2020
<ѻýҕl>PD-1 Inhibitor Active in Progressive Basal Cell Cancerѻýҕl> Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance Nov 11, 2020
<ѻýҕl>Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Comboѻýҕl> Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
<ѻýҕl>Demographics Make a Difference in Common Skin Cancersѻýҕl> Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
<ѻýҕl>Calcineurin Blockers for Eczema: No Cancer Signal in Big Studyѻýҕl> "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<ѻýҕl>Triplet OK'd as First-Line Therapy in Melanomaѻýҕl> Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<ѻýҕl>Cancer Immunotherapy Tied to Severe COVID-19 Outcomesѻýҕl> Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<ѻýҕl>Biologics Don't Increase Melanoma Risk... Probablyѻýҕl> Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<ѻýҕl>Face-Aging Selfies Help Modify Risky Skin Behaviors for Teensѻýҕl> Trial looked at effects of a free "UV-selfie" app May 07, 2020
<ѻýҕl>6-Week Keytruda Safe, Effective in Melanomaѻýҕl> Schedule gets FDA approval for all adult indications Apr 30, 2020
<ѻýҕl>Triplet Succeeds in BRAF-Mutant Melanomaѻýҕl> Immunotherapy plus BRAF/MEK inhibition boosts PFS over targeted agents alone Apr 27, 2020
<ѻýҕl>How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really?ѻýҕl> Real-world data offer word of caution for oncologists Apr 01, 2020
<ѻýҕl>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleedsѻýҕl> Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<ѻýҕl>Staving Off Sepsis; Bleeding and Fibroids: It's Double T Healthwatch!ѻýҕl> This week's topics also include blood levels of sunscreen ingredients, and fish oil and sperm quality Jan 25, 2020 podcast
<ѻýҕl>'Surprising' Number of Cancer Survivors Use Alcoholѻýҕl> Clinicians urged to step up alcohol screening at regular intervals, intervention Jan 22, 2020
<ѻýҕl>What Is Causing This Woman's Swollen Chin?ѻýҕl> A long and challenging diagnostic path with twists and turns Jan 20, 2020
<ѻýҕl>Rheumatoid Arthritis Is No Bar to Cancer Immunotherapyѻýҕl> Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them Nov 13, 2019
<ѻýҕl>Second Primary Melanoma Increases Risk for Deathѻýҕl> Data a reminder of the importance of regular skin exams Jun 27, 2019
<ѻýҕl>No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritisѻýҕl> Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
<ѻýҕl>Depth of Tumor Response a Better Survival Predictorѻýҕl> Could improve on RECIST as outcome measure in oncology Jun 05, 2019
<ѻýҕl>Predicting Disease Recurrence in Melanomaѻýҕl> But time to recurrence may poorly correlate with survival May 03, 2019